heiBIB: Mock, Andreas

Mock, Andreas M.Sc., M.Phil.; Dr. med.; Dr. rer. nat.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (42)
deutsch (1)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Nuzzolese, Imperia: Editorial: Diagnosis, epidemiology and treatment of salivary gland carcinomas / Imperia Nuzzolese, Pierluigi Bonomo, Ester Orlandi, Andreas Mock and Stefano Cavalieri, 20 February 2024. - 3 S.
In: Frontiers in oncology, ISSN 2234-943X. 14(2024), Seite 1-3
DOI: 10.3389/fonc.2024.1379584
Pixberg, Constantin Frederic: Reimbursement in the context of precision oncology approaches in metastatic breast cancer : challenges and experiences / Constantin Pixberg, Markus Schulze, Lars Buschhorn, Jan Philip Suppelna, Andreas Mock, Mario Hlevnja… , 2023. - 8 S. : Illustrationen
In: Breast care, ISSN 1661-3805. (2023), Seite 1-8
DOI: 10.1159/000533902
Mock, Andreas: Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing / Andreas Mock, Melissa Braun, Claudia Scholl, Stefan Fröhling & Cihan Erkut, 09 February 2023. - 11 S. : Illustrationen
In: Scientific reports, ISSN 2045-2322. 13(2023), Artikel-ID 2378, Seite 1-11
DOI: 10.1038/s41598-023-29550-8
Jahn, Arne: Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers / A. Jahn, A. Rump, T.J. Widmann, C. Heining, P. Horak, B. Hutter, N. Paramasivam, S. Uhrig, L. Gieldo… , 18 August 2022. - 14 S.
In: Annals of oncology, ISSN 1569-8041. 33(2022), 11, Seite 1186-1199
DOI: 10.1016/j.annonc.2022.07.008
Heilig, Christoph E.: Gene expression-based prediction of pazopanib efficacy in sarcoma / Christoph E. Heilig, Andreas Laßmann, Sadaf S. Mughal, Andreas Mock, Sebastian Pirmann, Veronica Tel… , 25 June 2022. - 12 S.
In: European journal of cancer, ISSN 1879-0852. 172(2022), Seite 107-118
DOI: 10.1016/j.ejca.2022.05.025
Möhrmann, Lino: Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity / Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Mock, Sebastian Uhrig, Arne Jahn, Simon K… , 02 August 2022. - 15 S.
In: Nature Communications, ISSN 2041-1723. 13(2022), Artikel-ID 4485, Seite 1-15
DOI: 10.1038/s41467-022-31866-4
Prasad, Manu: MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer / Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan, Avital B Shnerb, Sooraj Mathukkada, Jebrane Bouaoud… , March 15, 2022. - 16 S.
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. 10(2022), 3, Artikel-ID e003917, Seite 1-16
DOI: 10.1136/jitc-2021-003917
Heilig, Christoph E.: Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial / C.E. Heilig, P. Horak, S. Kreutzfeldt, V. Teleanu, A. Mock, M. Renner, I.A. Bhatti, B. Hutter, J. Hü… , 20 November 2021. - 5 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 6, Artikel-ID 100310, Seite 1-5
DOI: 10.1016/j.esmoop.2021.100310
Borchert, Florian: Knowledge bases and software support for variant interpretation in precision oncology / Florian Borchert, Andreas Mock, Aurelie Tomczak, Jonas Hügel, Samer Alkarkoukly, Alexander Knurr, An… , 10 May 2021. - 17 S.
In: Briefings in bioinformatics, ISSN 1477-4054. 22(2021), 6 vom: Nov., Artikel-ID bbab134, Seite 1-17
DOI: 10.1093/bib/bbab134
Yu, Tao: Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in vitro and in vivo / Tao Yu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollah… , 24 November 2021. - 16 S.
In: Cancers, ISSN 2072-6694. 13(2021), 23, Artikel-ID 5898, Seite 1-16
DOI: 10.3390/cancers13235898
Moratin, Julius: Digital pathology scoring of immunohistochemical staining reliably identifies prognostic markers and anatomical associations in a large cohort of oral cancers / Julius Moratin, Andreas Mock, Sonja Obradovic, Karl Metzger, Christa Flechtenmacher, Karim Zaoui, St… , 29 July 2021. - 11 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 29. Juli, Artikel-ID 712944, Seite 1-11
DOI: 10.3389/fonc.2021.712944
Mock, Andreas: EGFR and PI3K pathway activities might guide drug repurposing in HPV-negative head and neck cancers / Andreas Mock, Michaela Plath, Julius Moratin, Maria Johanna Tapken, Dirk Jäger, Jürgen Krauss, Stefa… , 11 June 2021. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 11. Juni, Artikel-ID 678966
DOI: 10.3389/fonc.2021.678966
Horak, Peter: Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers / Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Jennifer Hullein, M… , June 10, 2021. - 16 S.
In: Cancer discovery, ISSN 2159-8290. 11(2021), 11, Seite 2780-2795
DOI: 10.1158/2159-8290.CD-21-0126
Schnabel-Besson, Elena: Prognostic value of microRNA-221/2 and 17-92 families in primary glioblastoma patients treated with postoperative radiotherapy / Elena Schnabel, Maximilian Knoll, Christian Schwager, Rolf Warta, Andreas Mock, Benito Campos, Laila… , 15 March 2021. - 18 S.
In: International journal of molecular sciences, ISSN 1422-0067. 22(2021), 6, Artikel-ID 2960, Seite 1-18
DOI: 10.3390/ijms22062960
Golebiewska, Anna: Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology / Anna Golebiewska, Ann-Christin Hau, Anaïs Oudin, Daniel Stieber, Yahaya A. Yabo, Virginie Baus, Vane… , 3 October 2020. - 31 S.
In: Acta neuropathologica, ISSN 1432-0533. 140(2020), 6, Seite 919-949
DOI: 10.1007/s00401-020-02226-7
Mock, Andreas: Development and application of an R package for metabolomics / presented by Dr. med. Andreas Mock, M.Sc., M. Phil. ; referees: Prof. Dr. Benedikt Brors, Prof. Dr. … . -
Heidelberg, [2020?]. - v, 117 Seiten : Illustrationen, Diagramme
Walle, Thomas: Completion rate and impact on physician-patient relationship of video consultations in medical oncology : a randomised controlled open-label trial / Thomas Walle, Erkin Erdal, Leon Mühlsteffen, Hans Martin Singh, Editha Gnutzmann, Barbara Grün, Hele… , 2020. - 9 S.
In: ESMO open, ISSN 2059-7029. 5(2020,6) Artikel-Nummer e000912, 9 Seiten
DOI: 10.1136/esmoopen-2020-000912
Scherr, Anna-Lena: Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer / Anna-Lena Scherr, Andreas Mock, Georg Gdynia, Nathalie Schmitt, Christoph E. Heilig, Felix Korell, P… , 17 October 2020. - 16 S.
In: Cell death & disease, ISSN 2041-4889. 11(2020), 10, Seite 1-16
DOI: 10.1038/s41419-020-03092-7
Pocha, Kolja: Surfactant expression defines an inflamed subtype of lung adenocarcinoma brain metastases that correlates with prolonged survival / Kolja Pocha, Andreas Mock, Carmen Rapp, Steffen Dettling, Rolf Warta, Christoph Geisenberger, Christ… , May 2020. - 13 S.
In: Clinical cancer research, ISSN 1557-3265. 26(2020), 9, Seite 2231-2243
DOI: 10.1158/1078-0432.CCR-19-2184
Voronina, Natalia: The landscape of chromothripsis across adult cancer types / Natalia Voronina, John K.L. Wong, Daniel Hübschmann, Mario Hlevnjak, Sebastian Uhrig, Christoph E. H… , 08 May 2020. - 13 S.
In: Nature Communications, ISSN 2041-1723. 11(2020) Artikel-Nummer 2320, 13 Seiten
DOI: 10.1038/s41467-020-16134-7
Mock, Andreas: Community-driven development of a modified progression-free survival ratio for precision oncology / Andreas Mock, Christoph E Heilig, Simon Kreutzfeldt, Daniel Huebschmann, Christoph Heining, Evelin S… , November 13, 2019. - 6 S. : Diagramme
In: ESMO open, ISSN 2059-7029. 4(2019) Artikel-Nummer e00058, 6 Seiten
DOI: 10.1136/esmoopen-2019-000583
Rapp, Carmen: Cytotoxic T cells and their activation status are independent prognostic markers in meningiomas / Carmen Rapp, Steffen Dettling, Fang Liu, Anna Theresa Ull, Rolf Warta, Christine Jungk, Saskia Roesc… , June 21, 2019. - 11 S.
In: Clinical cancer research, ISSN 1557-3265. 25(2019), 17, Seite 5260-5270
DOI: 10.1158/1078-0432.CCR-19-0389
Akbaba, Sati: Treatment outcome of 227 patients with sinonasal adenoid cystic carcinoma (ACC) after intensity modulated radiotherapy and active raster-scanning carbon ion boost : a 10-year single-center experience / Sati Akbaba, Dina Ahmed, Andreas Mock, Thomas Held, Suzan Bahadir, Kristin Lang, Mustafa Syed, Julia… , 1 November 2019. - 14 S.
In: Cancers, ISSN 2072-6694. 11(2019,11) Artikel-Nummer 1705, 14 Seiten
DOI: 10.3390/cancers11111705
Akbaba, Sati: The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck : A 15-year single-center experience / Sati Akbaba, Astrid Heusel, Andreas Mock, Thomas Held, Kristin Lang, Juliane Hoerner-Rieber, Tobias … , 05 September 2019. - 9 S.
In: Oral oncology, ISSN 1879-0593. 97(2019), Seite 115-123
DOI: 10.1016/j.oraloncology.2019.08.018
Akbaba, Sati: Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck / Sati Akbaba, Andreas Mock, Juliane Hoerner-Rieber, Thomas Held, Sonja Katayama, Tobias Forster, Chri… , 13 August 2019. - 11 S.
In: Frontiers in oncology, ISSN 2234-943X. 9(2019) Artikel-Nummer 755, 11 Seiten
DOI: 10.3389/fonc.2019.00755
Mock, Andreas: Impact of post-surgical freezing delay on brain tumor metabolomics / Andreas Mock, Carmen Rapp, Rolf Warta, Amir Abdollahi, Dirk Jäger, Oliver Sakowitz, Benedikt Brors, … , 13 May 2019. - 8 S.
In: Metabolomics, ISSN 1573-3890. 15(2019,5) Artikel-Nummer 78, 8 Seiten
DOI: 10.1007/s11306-019-1541-2
Jungk, Christine: Location-dependent patient outcome and recurrence patterns in IDH1-wildtype glioblastoma / Christine Jungk, Rolf Warta, Andreas Mock, Sara Friauf, Bettina Hug, David Capper, Amir Abdollahi, J… , 21 January 2019. - 17 S.
In: Cancers, ISSN 2072-6694. 11(2019,1) Artikel-Nummer 122, 17 Seiten
DOI: 10.3390/cancers11010122
Mock, Andreas: MetaboDiff : an R package for differential metabolomic analysis / Andreas Mock, Rolf Warta, Steffen Dettling, Benedikt Brors, Dirk Jäger, Christel Herold-Mende, 26 April 2018. - 2 S.
In: Bioinformatics, ISSN 1367-4811. 34(2018), 19, Seite 3417-3418
DOI: 10.1093/bioinformatics/bty344
DeWitt, John C.: The 2016 Who classification of central nervous system tumors : what neurologists need to know / John C. Dewitt, Andreas Mock, David N. Louis, 2017/12/01. - 7 S.
In: Current opinion in neurology, ISSN 1473-6551. 30(2017), 6, Seite 643-649
DOI: 10.1097/WCO.0000000000000490
Mock, Andreas: Genomweite DNA-Methylierungsanalyse in langzeitüberlebenden Glioblastompatienten / vorgelegt von Andreas Mock. -
Heidelberg, 2017. - iv, 86 Blätter : Illustrationen, Diagramme
Mock, Andreas: Non-invasive glioblastoma immunoprofiling by printed peptide arrays / Andreas Mock and Christel Herold-Mende, 26 Feb 2016. - 3 S.
In: OncoImmunology, ISSN 2162-402X. 5(2016,2) Artikel-Nummer e106994, 3 Seiten
DOI: 10.1080/2162402X.2015.1069941
Jungk, Christine: Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone / Christine Jungk, Andreas Mock, Janina Exner, Christoph Geisenberger, Rolf Warta, David Capper, Amir … , [2016]. - 16 S.
In: BMC medicine, ISSN 1741-7015. 14(2016) Artikel-Nummer 170, 16 Seiten
DOI: 10.1186/s12916-016-0710-7
Schmidt, Melissa: Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade / Melissa Schmidt, Andreas Mock, Christine Jungk, Felix Sahm, Anna Theresa Ull, Rolf Warta, Katrin Lam… , February 15, 2016. - 18 S.
In: OncoTarget, ISSN 1949-2553. 7(2016), 12, Seite 14551-14568
DOI: 10.18632/oncotarget.7396
Schmoch, Thomas: Combined treatment of ATRA with epigenetic drugs increases aggressiveness of glioma xenografts. / Thomas Schmoch, Zoltan Gal, Andreas Mock, Jan Mossemann, Bernd Lahrmann, Niels Grabe, Peter Schmezer… , 1 April 2016. - 8 S.
In: Anticancer research, ISSN 1791-7530. 36(2016), 4, Seite 1489-1496
Mock, Andreas: LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients / Andreas Mock, Christoph Geisenberger, Christian Orlik, Rolf Warta, Christian Schwager, Christine Jun… , 2 March 2016. - 9 S.
In: International journal of cancer, ISSN 1097-0215. 139(2016), 2, Seite 424-432
DOI: 10.1002/ijc.30069
Jungk, Christine: Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status : a single-center volumetric analysis / Christine Jungk, Moritz Scherer, Andreas Mock, David Capper, Alexander Radbruch, Andreas von Deimlin… , 25 June 2016. - 10 S.
In: Journal of neuro-oncology, ISSN 1573-7373. 129(2016), 2, Seite 319-328
DOI: 10.1007/s11060-016-2177-y
Jungk, Christine: Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone / Christine Jungk, Andreas Mock, Janina Exner, Christoph Geisenberger, Rolf Warta, David Capper, Amir … . -
London; Berlin; Heidelberg: BioMed Central; Springer, 26 October 2016. - 1 Online-Ressource (16 Seiten)
DOI: 10.1186/s12916-016-0710-7
Lohr, Jennifer: Endothelial cells derived from non-malignant tissues are of limited value as models for brain tumor vasculature / Jennifer Lohr, Andreas Mock, Philipp Beckhove and Christel Herold-Mende, March 2, 2015. - 10 S.
In: Anticancer research, ISSN 1791-7530. 35(2015), 5, Seite 2681-2690
Geisenberger, Christoph: Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain / Christoph Geisenberger; Andreas Mock; Rolf Warta; Carmen Rapp; Christian Schwager; Andrey Korshunov;… , 2015. - 16 S.
In: Acta neuropathologica, ISSN 1432-0533. 130(2015), 3, Seite 419-434
DOI: 10.1007/s00401-015-1427-y
Mock, Andreas: Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients / Andreas Mock, Rolf Warta, Christoph Geisenberger, Ralf Bischoff, Alexander Schulte, Katrin Lamszus, … , 2015. - 12 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 15, Seite 13579-13590
DOI: 10.18632/oncotarget.3791
Mock, Andreas: Lessons we learned from high-throughput and top-down systems biology analyses about glioma stem cells / Andreas Mock, Sara Chiblak and Christel Herold-Mende, 2014. - 7 S.
In: Current pharmaceutical design, ISSN 1873-4286. 20(2014), 1, Seite 66-72
Herold-Mende, Christel: Microenvironment and brain tumor stem cell maintenance : impact of the niche / Christel Herold-Mende and Andreas Mock, August 2014. - 10 S.
In: Anti-cancer agents in medicinal chemistry, ISSN 1875-5992. 14(2014), 8, Seite 1065-1074
DOI: 10.2174/1871520614666140825103636
Warta, Rolf: Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients / Rolf Warta, Christel Herold-Mende, Jittiporn Chaisaingmongkol, Odilia Popanda, Andreas Mock, Carolin… , 2014. - 8 S.
In: International journal of cancer, ISSN 1097-0215. 135(2014), 11, Seite 2727-2734
DOI: 10.1002/ijc.28906

IDs

GND:	1071913905

Links

Mock, Andreas in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design